| Immunomodulatory functions of BTLA and HVEM govern induction of extrathymic regulatory T cells and tolerance by dendritic cells A Jones, J Bourque, L Kuehm, A Opejin, RM Teague, C Gross, D Hawiger Immunity 45 (5), 1066-1077, 2016 | 158 | 2016 |
| Fructose promotes cytoprotection in melanoma tumors and resistance to immunotherapy LM Kuehm, N Khojandi, A Piening, LE Klevorn, SC Geraud, ... Cancer immunology research 9 (2), 227-238, 2021 | 23 | 2021 |
| Oxidized lipoproteins promote resistance to cancer immunotherapy independent of patient obesity N Khojandi, LM Kuehm, A Piening, MJ Donlin, EC Hsueh, TL Schwartz, ... Cancer immunology research 9 (2), 214-226, 2021 | 22 | 2021 |
| Rescue of Tolerant CD8+ T Cells during Cancer Immunotherapy with IL2:Antibody Complexes LE Klevorn, MM Berrien-Elliott, J Yuan, LM Kuehm, GD Felock, SA Crowe, ... Cancer immunology research 4 (12), 1016-1026, 2016 | 22 | 2016 |
| Interleukin 27 protects from gastric atrophy and metaplasia during chronic autoimmune gastritis KA Bockerstett, CP Petersen, CN Noto, LM Kuehm, CF Wong, EL Ford, ... Cellular and molecular gastroenterology and hepatology 10 (3), 561-579, 2020 | 21 | 2020 |
| Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity LM Kuehm, K Wolf, J Zahour, RJ DiPaolo, RM Teague Cancer Immunology, Immunotherapy 68, 1095-1106, 2019 | 9 | 2019 |
| Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk A Piening, E Ebert, C Gottlieb, N Khojandi, LM Kuehm, SG Hoft, KD Pyles, ... Nature Communications 15 (1), 2835, 2024 | | 2024 |
| High dimensional analyses reveal IL-15 enhances activation of Sipuleucel-T lymphocyte subsets and reverses immunoresistance MA Saeed, B Peng, K Kim, K Rawat, LM Kuehm, ZR Siegel, A Borkowski, ... Cancer Immunology Research, 2024 | | 2024 |
| Teaching old CAR-T cells new tricks LM Kuehm, RM Teague Journal of Leukocyte Biology 102 (2), 188-190, 2017 | | 2017 |
